至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition

Nature Biotechnology. 2026-07; 
Junjie Zhu, Lin Ding, Kai-Ming Liu, Xingyu Zhu, Jifang Li, Buer Ha, Bao-Qing Gao, Xujiao Zhou, Chengfang Liu, Jia Wei, Shuangyu Ma, Wenchao Xu, Lingyun Kong, Jing Wu, Xiaodun Mou, Bei Yang, Lijie Wang, Jiaxu Hong, Li Yang & Jia Chen
Products/Services Used Details Operation
Gene Synthesis XTEN and COM inserts from pN22p-UGI and pUC57-COM (synthesized by GenScript), respectively. Then, NLS-UGI, XTEN and COM inserts and the linear pMMLVgag(C507V)-3×NES vector were recombined to generate the pMMLVgag(C507V)-UGI-COM. Cells and VLPs were lysed in protein loading buffer (TransGen Biotech, DL101) and incubated at 95 °C for 20 min, before being separated by SDS–PAGE (Genscript, M00661) in loading buffer. Modified sgRNA for mouse studies was synthesized by GenScript. Get A Quote
Synthetic Guide RNA Get A Quote

摘要

Virus-like particles (VLPs) are promising for delivering genome editors, yet the in vivo in vivo efficacy of VLP-mediated cytosine base editing remains limited. Here we identified insufficient inhibition of uracil DNA glycosylases as the underlying mechanism of low cytosine base editor (CBE) editing efficiencies in vivo. We engineered a previously reported CBE, transformer base editor (tBE), and developed a VLP delivery system to enhance the recruitment of uracil DNA glycosylase inhibitor proteins. tBE-VLPs achieved robust C-to-T editing in mouse liver and retina. A single injection achieved, on average, 46.0% editing at mPcsk9 and 64.2% at mHpd in the liver, as well as 24.2% at mVegfa in the retinal pigment ep... More

关键词